DERMABOND™ PRINEO™ Skin Closure System
DERMABOND™ PRINEO™ Skin Closure System
DERMABOND™ PRINEO™ Skin Closure System provided a flexible microbial barrier with 98.43% protection in vitro for 72 hours against organisms commonly responsible for SSIs.1,I,II
MEDIA
DERMABOND™ PRINEO™ Skin Closure System provided a flexible microbial barrier with 98.43% protection in vitro for 72 hours against organisms commonly responsible for SSIs.1,I,II
DERMABOND™ PRINEO™ Skin Closure System was shown to provide statistically significant greater skin holding strength than skin staples or subcuticular 4-0 MONOCRYL (poliglecaprone 25) suture.2,iii,iv
DERMABOND™ PRINEO™ led to greater overall patient satisfaction when compared to skin staples.3-5,v
Different Choices,
Different Results
Choose STRATAFIX™ Knotless Tissue Control Devices and DERMABOND™ PRINEO™ Skin Closure System.6
Traditional wound closure techniques involving conventional suture, staples and wound dressings may not be the optimal choice to achieve the primary objective of multi-layer, watertight closure.6
Reducing risk factors and improving healing can be achieved with appropriate surgical technique and postoperative care. You can optimise tissue management through the principles of wound healing: gentle handling of tissues, careful haemostasis, obliteration of dead space, and avoidance of tension.7,8 Appropriate choice of wound dressing should manage wound bioburden, limit cross contamination and promote a wound healing environment. 9
Let’s work together to reduce infection risk, shorten length of stay and minimise readmissions.
DERMABOND™ PRINEO™ Skin Closure System vs. traditional sutures and staples respectively, were associated with:
Close faster with DERMABOND™ PRINEO™.10,vi,vii
DERMABOND™ PRINEO™: 98.43% protection. 1,ii,viii
DERMABOND™ PRINEO™ reduced readmission rates. 11,12,ix,x
DERMABOND™ PRINEO™ allows for visibility of the wound.13,14,xi,xii
DERMABOND™ PRINEO™: less post-op care.3,v
DERMABOND™ PRINEO™ increased patient satisfaction.3-5,xiii
DERMABOND™ PRINEO™ Videos
Watch DERMABOND PRINEO being used in a knee arthroplasty case
06:02
Patient video to help care for their wound following knee surgery with DERMABOND PRINEO.
01:31
Patient video to help care for their wound following Caesarean section with DERMABOND PRINEO.
01:31
Supporting Documentation
Product Support
-
Tips for Optimal Closure with DERMABOND PRINEO
View PDF
-
Recommendations to Help Minimize Skin Reactions
View PDF
-
Economic and Clinical Outcomes vs Skin Staples in Total Knee Arthroplastyxiv
View PDF
-
Cost Savings via Reduced Resource Utilization in the Post-acute Care Settingxiv
View PDF
-
Wound-healing Delays and Reoperations vs a Topical Skin Adhesive with Silver Dressings after Knee Arthroplasty
View PDF
-
Select all documents (5)
Helpful Links
Hip Arthroplasty
Knee Arthroplasty
Care4today
Ethicon Home
Ethicon Customer Support
© Johnson & Johnson Medical NV., 2023.
This site is published by Johnson & Johnson Medical N.V., which is solely responsible for its contents and is intended for EMEA audiences only. This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.
*As of March 2017, per internal research conducted by Ethicon.
Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.